When to cryopreserve ovarian tissue: Determining the effects of chemotherapy on the ovarian reserve by studying follicular density and apoptosis
Cytopathology · 2023-03 · 34 (2) · 146-153
DOI: 10.1111/cyt.13194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytopathology, online erschienen am 19.12.2022. Verfasst von Elsa Labrune und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, Bron, France. Hauptthemen laut MEDLINE: Ovarian Reserve. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
Patients scheduled to receive chemotherapy should be counselled on fertility preservation. Known gonadotoxic chemotherapies such as alkylating agents have a high risk of altering ovarian reserve. In some cases, the urgency of treatment requires the use of chemotherapy before fertility preservation, which will be carried out at a later stage. Usually the ovarian tissue is cryopreserved. The aim of our study is to investigate the impact of chemotherapies on follicular density and the apoptosis of reserve follicles.
Methods
We included 140 patients: 63 patients, mean age 18.8 years, were included in the group “no chemotherapy” (group A) and 77 patients, mean age 17.1 years, in the group “received chemotherapy before ovarian conservation” (group B). None of the patients had had pelvic radiotherapy prior to ovarian cryopreservation. The histological parameters studied were follicular density and the presence of malignant cells. We selected 12 patients from group A and 15 patients from group B, comparable in age and pathology, for whom we evaluated follicle apoptosis by immunostaining cleaved caspase‐3.
Results
We demonstrated an inverse relationship between follicular density and age ( p < 0.0001), as well as a lack of effect of chemotherapy on follicular density ( p = 0.87). We showed the impact of various chemotherapies, especially with alkylating agents, on the apoptosis of ovarian follicles ( p < 0.0001). Three patients had ovarian tissue infiltration, two of which were malignant.
Conclusion
This work underlines the fact that conservation of ovarian tissue after chemotherapy remains possible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospices Civils de Lyon, Hôpital Mère Enfant, Service de Médecine de la Reproduction, Bron, France.
- Université Claude Bernard, Faculté de Médecine Laennec, Lyon Cedex 08, France.
- INSERM Unité 1208, Bron Cedex, France.
- Université Claude Bernard, Faculté de Médecine Lyon Sud, Oullins Cedex, France.
ORCID-Profile: Elsa Labrune
Zitieren
APA
Labrune, E., Bianchetti, S., Lepinasse, O., Soignon, G., Salle, B., & Lornage, J. (2023). When to cryopreserve ovarian tissue: Determining the effects of chemotherapy on the ovarian reserve by studying follicular density and apoptosis. Cytopathology, 34(2), 146-153. https://doi.org/10.1111/cyt.13194
Vancouver
Labrune E, Bianchetti S, Lepinasse O, Soignon G, Salle B, Lornage J. When to cryopreserve ovarian tissue: Determining the effects of chemotherapy on the ovarian reserve by studying follicular density and apoptosis. Cytopathology. 2023;34(2):146-153. doi:10.1111/cyt.13194
BibTeX
@article{Labrune2023,
author = {Labrune, Elsa and Bianchetti, Serge and Lepinasse, Odile and Soignon, Gaelle and Salle, Bruno and Lornage, Jacqueline},
title = {When to cryopreserve ovarian tissue: Determining the effects of chemotherapy on the ovarian reserve by studying follicular density and apoptosis},
journal = {Cytopathology},
year = {2023},
volume = {34},
number = {2},
pages = {146--153},
doi = {10.1111/cyt.13194}
}
EUVIMED